Search All News
Source:Columbia Medicine Magazine
Dr. Neil Shneider, MD, PhD, director of the Eleanor and Lou Gehrig ALS Center, requested a one-time experimental therapy treatment through the FDA which has evolved into a multicenter clinical trial.
Patients at Columbia are pursuing custom-designed ASO therapies. These compounds lend themselves to personalization.
Wings over Wall Street gala for the MDA research program on ALS honored Dr. Shneider with the Diamond Award. In recognition of his scientific leadership and dedication to the eradication of ALS.
See Dr. Shneider's interview with Today show reflecting on the efforts to find a cure and treatments through the continued work of our team at the Columbia Eleanor & Lou Gehrig ALS Center.
- January 5, 2019
Project Revoice aims to help those living with ALS with recording and recreating their natural voices for future use.
- March 2, 2018
We are excited to announce the opening of a new office location at Columbia Doctors located at 155 White Plains Rd, Tarrytown, NY 10591.
Source:U.S. Food and Drug Administration NewsroomMay 5, 2017
The FDA released information regarding the recent approval of a new intravenous infusion called Radicava, also known as Edaravone.